• Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

This page contains brief information about ofatumumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA Approval for Ofatumumab (2016)

FDA Approval for Ofatumumab (2009 and 2014)

Use in Cancer

Ofatumumab is approved to be used alone or with other drugs to treat:

Ofatumumab is also being studied in the treatment of other types of cancer.

More About Ofatumumab

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Ofatumumab - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Ibrutinib Improves Survival Compared With Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Ofatumumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: November 20, 2009
  • Updated: December 15, 2017